findmyKOL

Gilbert Daniels, MD

Basic profile

Harvard University

ORCID↗NPI↗
✓ Full record
RegionBoston, MA · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2019EmergingfindmyKOL type: RegionalLatest publication2019Online presenceNot yet checkedPaymentsNone reportedNIH funding1997–1997Why? →

Gilbert Daniels is an Endocrinology/Metabolic physician affiliated with Harvard University. OpenAlex indexes 229 publications with 20,301 citations (h-index 56). By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
229publications

Distinct works indexed by OpenAlex, matched via ORCID.

20,301citations

Total citations across indexed works.

56h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1997–1997

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

15 Parkman St
Thyroid Associates Wac 730s
Boston, MA 021143117

Telephone

617-726-8430

Registry record last updated 8 Jan 2013.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    94.3%
    l-Thyroxine77.7%
    Levothyroxine Sodium81%Synthroid18%Levoxyl1%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor9.9%
    Methimazole100%
    Part D≥41 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    4.9%
    Corticosteroid3.1%
    Prednisone100%
    Part D<11 patients
    Vitamin D3 Analog1.8%
    Calcitriol100%
    Part D<11 patients
  • Nervous system

    0.8%
    Ergot Derivative0.8%
    Cabergoline100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 1997–1997 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”